Defense World
26 Dec 2025, 06:26 UTC · 45w ago
Verdict
Headline takes no side. We score INKT −0.20 across one claim — slightly bearish.
−0.20slightly bearish
More negative than 70% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
What the story claims
1 claim · scored −1 bearish … +1 bullish
MiNK Therapeutics (INKT) has an average analyst rating of 'Hold' from five research firms.
So whatA consensus 'Hold' rating typically indicates a neutral market expectation with no strong catalyst for price movement.
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
Continue reading
5 related stories
More negative than 70% of ticker scores this week
The company has an average rating of 'Hold' with at least one sell recommendation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
—
No price for INKT right now — the quote feed didn't answer.
INKT chart →
